Myoelectric Activity Following Colorectal Surgery and Return of Bowel Function
1 other identifier
interventional
77
1 country
1
Brief Summary
The purpose of the study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them. These pilot prospective, open clinical studies suggests that myoelectrical activity, measured on the abdominal surface with a noninvasive wireless patch system, carries predictive value in determining time to feeding and time to flatus following open abdominal surgery. Having such information in advance of clinical measures could facilitate timely interventions, be it early feeding or delaying feeding as dictated by the patient's unique recovery profile. The G-Tech Wireless Patch System would provide a unique insight into the process allowing for a tailored protocol that could improve patient satisfaction and optimize recovery. The system could also enable feedback on the impact to the overall gastrointestinal myoelectrical activity of medications, particularly opioids, used for pain management that are known to inhibit gastrointestinal function by disrupting the normal recovery patterns of colonic motility.23-25 While it remains to be seen, in addition to predicting time to flatus/bowel movement early on, the ability to continue monitoring the patient may allow one to predict onset of secondary complications, such as wound infections or anastomotic leaks, that are associated with ileus. Similarly, given the wireless noninvasive nature of the system the patients could be discharged home with the patches, whereby they would serve as a remote monitoring tool. This could be particularly useful in cases where the patients may have been discharged early and may be at a high risk for readmission. The system would then send updates/alerts to the care team for management and potentially avoid preventable readmissions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2022
CompletedFirst Posted
Study publicly available on registry
March 28, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedResults Posted
Study results publicly available
August 3, 2025
CompletedAugust 3, 2025
July 1, 2025
2.3 years
March 17, 2022
July 3, 2025
July 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
GI Functional Recovery
Time to return of flatus or bowel movement after colorectal surgery
30 days after index surgery
Secondary Outcomes (2)
Postoperative Ileus
30 days after index surgery
Readmission With Ileus
30 days after index surgery
Study Arms (1)
Postoperative recovery with G-tech WPS
EXPERIMENTALInterventions
G-tech WPS patches applied and activated within 4 hours of surgery
Eligibility Criteria
You may qualify if:
- Willing and able to provide informed consent
- Eighteen (18) years of age or older
- Subject is willing and able to follow all study requirements
- Subject has undergone or will undergo a laparoscopic or open colorectal surgery with resection and anastomosis
You may not qualify if:
- Subject is pregnant or suspects pregnancy.
- Known allergy to medical grade adhesive.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- G-Tech Corporationcollaborator
Study Sites (1)
Yale New Haven Hospital
New Haven, Connecticut, 06519, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study is limited by a short follow-up duration restricted to in-patient settings and aligning myoelectric readings with clinical symptoms is under-powered.
Results Point of Contact
- Title
- Dr. Ira Leeds
- Organization
- Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2022
First Posted
March 28, 2022
Study Start
June 1, 2022
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
August 3, 2025
Results First Posted
August 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share